A new treatment for chronic pain in the vaginal area
Official title: Mucoadhesive film for the treatment of vestibulodynia
Funded at Anelleo, INC. · NIH-10932143 · Data updated 2026-11-12
This study is testing a new type of film that sticks to the skin to help relieve the pain of vestibulodynia, making it easier for women to get the right medication right where they need it, so they can feel more comfortable in their daily lives.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Anelleo, INC. NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,105,469 |
| NIH project number | 5R44HD112245-02 |
| Project ID | NIH-10932143 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women of reproductive age who experience chronic pain in the vaginal area due to vestibulodynia.
✕Less likely to help
Patients who do not have vestibulodynia or those with other unrelated chronic pain conditions may not benefit from this research.
What this research studies
This research focuses on developing a mucoadhesive film designed to treat vestibulodynia, a chronic pain condition affecting the vaginal vestibule. The film aims to provide a more effective and localized delivery of medication compared to traditional topical treatments, which can be difficult to apply and have a short duration of effect. By improving the delivery system, the research seeks to alleviate the burning, stinging, and stabbing sensations that many women experience during everyday activities. Patients will be involved in testing the effectiveness and comfort of this new treatment method.
Why it matters
Potential benefit: If successful, this research could significantly reduce pain and improve the quality of life for women suffering from vestibulodynia.
How similar studies have gone: Previous research has shown promise in developing innovative drug delivery systems for localized treatment of chronic pain conditions, suggesting potential success for this approach.
Where this research is happening
-
Anelleo, INC.
Chapel Hill, United States Active
Researchers
- Principal investigator: Janusziewicz, Rima — Anelleo, INC.
- Study coordinator: Janusziewicz, Rima
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.